EUVIMEDEUVIMED entdecken
KorrekturOpen Access · CC BY-NC 3.0

Early PIVKA-II Response Predicts Treatment Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma [Corrigendum]

Ching-Tso Chen, Chien-Huai Chuang, Chih-Hung Hsu, Yu-Yun Shao

Journal of Hepatocellular Carcinoma · 2026-03 · Volume 13 · 1-1

DOI: 10.2147/jhc.s611160 ↗

Kurz gefasst

Korrektur in der Zeitschrift Journal of Hepatocellular Carcinoma, 2026-03. Verfasst von Ching-Tso Chen und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Chen, C., Chuang, C., Hsu, C., & Shao, Y. (2026). Early PIVKA-II Response Predicts Treatment Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma [Corrigendum]. Journal of Hepatocellular Carcinoma, Volume 13, 1-1. https://doi.org/10.2147/jhc.s611160

Vancouver

Chen C, Chuang C, Hsu C, Shao Y. Early PIVKA-II Response Predicts Treatment Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma [Corrigendum]. Journal of Hepatocellular Carcinoma. 2026;Volume 13:1-1. doi:10.2147/jhc.s611160

BibTeX
@article{Chen2026,
  author = {Chen, Ching-Tso and Chuang, Chien-Huai and Hsu, Chih-Hung and Shao, Yu-Yun},
  title = {Early PIVKA-II Response Predicts Treatment Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma [Corrigendum]},
  journal = {Journal of Hepatocellular Carcinoma},
  year = {2026},
  volume = {Volume 13},
  pages = {1--1},
  doi = {10.2147/jhc.s611160}
}
Kostenlos starten →